Literature DB >> 2140378

Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study.

J Aagaard1, P Vestergaard.   

Abstract

The purpose of this study of 133 affective disorder patients consecutively referred to start prophylactic lithium treatment was to identify informative predictors of outcome. Non-adherence to treatment was mainly predicted by substance abuse and many earlier admissions. Non-response among the 78 patients adhering to lithium treatment was mainly predicted by female sex, young age and previously chronic course. The overall response rate was rather poor and an excess mortality rate was found. It is suggested that patients with substance abuse should not be offered prophylactic lithium treatment unless intensive control and support is practicable, and patients with a chronic course need a more effective treatment than lithium can offer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140378     DOI: 10.1016/0165-0327(90)90077-l

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  A randomized, double-blind, placebo-controlled, trial of lamotrigine therapy in bipolar disorder, depressed or mixed phase and cocaine dependence.

Authors:  E Sherwood Brown; Prabha Sunderajan; Lisa T Hu; Sharon M Sowell; Thomas J Carmody
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  What do patients in a lithium outpatient clinic know about lithium therapy?

Authors:  R T Schaub; A Berghoefer; B Müller-Oerlinghausen
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

Review 3.  Long term treatment of bipolar disorder.

Authors:  T Silverstone; S Romans
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 4.  Pharmacologic treatment of geriatric mania.

Authors:  William M McDonald; John Wermager
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

Review 5.  The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse.

Authors:  C L Bowden
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 6.  The psychopathology and treatment of bipolar disorder.

Authors:  David J Miklowitz; Sheri L Johnson
Journal:  Annu Rev Clin Psychol       Date:  2006       Impact factor: 18.561

7.  A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.

Authors:  E Sherwood Brown; Thomas J Carmody; Joy M Schmitz; Raul Caetano; Bryon Adinoff; Alan C Swann; A John Rush
Journal:  Alcohol Clin Exp Res       Date:  2009-08-10       Impact factor: 3.455

8.  Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement.

Authors:  Enrique Baca-Garcia; Leo Sher; M Mercedes Perez-Rodriguez; Ainsley K Burke; Gregory M Sullivan; Michael F Grunebaum; Barbara H Stanley; J John Mann; Maria A Oquendo
Journal:  J Affect Disord       Date:  2008-10-29       Impact factor: 4.839

9.  A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.

Authors:  E Sherwood Brown; Domingo Davila; Alyson Nakamura; Thomas J Carmody; A John Rush; Alexander Lo; Traci Holmes; Bryon Adinoff; Raul Caetano; Alan C Swann; Prabha Sunderajan; Mary E Bret
Journal:  Alcohol Clin Exp Res       Date:  2014-06-27       Impact factor: 3.455

10.  Efficacy of lithium prophylaxis in bipolar affective disorder.

Authors:  M R Mathew; R Chandrasekaran; S S Shreeram; I Anand
Journal:  Indian J Psychiatry       Date:  1995-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.